Cancer Research UK on Google+ Cancer Research UK on Facebook Cancer Research UK on Twitter
 
Skip navigation

Our research into biomarkers

Biomarkers are substances that doctors can measure, for example in samples of blood or urine, which help them monitor how a disease is developing or whether a treatment is working. By testing for certain molecules in the bloodstream, it’s becoming possible to detect some types of cancer at an early stage, when they are more likely to be treated successfully. Biomarkers are also essential for monitoring a patient’s cancer, to see how it responds to treatment.

Cancer Research UK scientists are looking for new biomarkers, and trying to find ways to improve existing ones.

Finding new biomarkers is crucial in the drive to more ‘personalised’ cancer care. Together with our growing understanding of the genetic changes that contribute to cancer, biomarker research will lead to targeted screening programmes and better ways to treat and monitor individual patients.

Below are some of the highlights of our biomarker research portfolio.

Researcher listing

9 researchers found. Filter results:

Researcher David Adams profile image
David Adams

Searching for early signs of cancer
Experimental Mouse Genetics

Wellcome Trust Sanger Institute

Researcher Tim Bishop profile image
Tim Bishop

Finding cancer genes
Section of Epidemiology and Biostatistics, LIMM

University of Leeds

Default user avatar
Heike Grabsch

Personalised treatment for oesophageal cancer
Leeds Institute of Molecular Medicine

University of Leeds

Default user avatar
Gareth Griffiths

Getting the most out of clinical trials
University of Southampton Clinical Trials Unit

University of Southampton

Researcher Paddy Johnston profile image
Patrick Johnston

Understanding drug resistance in bowel cancer

Queen's University of Belfast

Default user avatar
Nick Lemoine

Developing new ways to diagnose and treat cancer
Institute of Cancer

Queen Mary, University of London

Default user avatar
Ross Maxwell

Newcastle University

Default user avatar
Gareth Morgan

Improving treatment for multiple myeloma
Molecular HaematologyTeam

Institute of Cancer Research

Researcher Christina Thirlwell profile image
Christina Thirlwell

Understanding rare neuroendocrine tumours
UCL Cancer Institute

University College London

Updated: 18 February 2010